A mAb to SIRPα downregulates the priming of naive CD4 + T cell in Primary immune thrombocytopenia.

[1]  W. Liu,et al.  Interleukin 35 may contribute to the loss of immunological self‐tolerance in patients with primary immune thrombocytopenia , 2015, British journal of haematology.

[2]  Yunfeng Cheng,et al.  Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients , 2014, Immunologic Research.

[3]  D. Sugiyama,et al.  Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individuals , 2014, Science.

[4]  J. Freedman,et al.  Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia. , 2012, Blood.

[5]  L. Walker,et al.  The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses , 2011, Nature Reviews Immunology.

[6]  T. Petrella,et al.  Immunologic effects of rituximab on the human spleen in immune thrombocytopenia. , 2011, Blood.

[7]  G. Anderson,et al.  Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4 , 2011, Science.

[8]  S. Heck,et al.  Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. , 2009, Blood.

[9]  Yuan Yu,et al.  De novo induction of platelet-specific CD4(+)CD25(+) regulatory T cells from CD4(+)CD25(-) cells in patients with idiopathic thrombocytopenic purpura. , 2009, Blood.

[10]  B. Olsson,et al.  Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1. , 2008, Blood.

[11]  S. Amadori,et al.  Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. , 2008, Blood.

[12]  K. Boyd,et al.  The inhibitory cytokine IL-35 contributes to regulatory T-cell function , 2007, Nature.

[13]  D. Glass,et al.  Autoantigen-Specific TGFβ-Induced Foxp3+ Regulatory T Cells Prevent Autoimmunity by Inhibiting Dendritic Cells from Activating Autoreactive T Cells1 , 2007, The Journal of Immunology.

[14]  C. Ruan,et al.  Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high‐dose dexamethasome , 2007, European journal of haematology.

[15]  T. Matozaki,et al.  Resistance to Experimental Autoimmune Encephalomyelitis and Impaired T Cell Priming by Dendritic Cells in Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 Mutant Mice1 , 2007, The Journal of Immunology.

[16]  R. Steinman,et al.  Dendritic cells with TGF-β1 differentiate naïve CD4+CD25− T cells into islet-protective Foxp3+ regulatory T cells , 2007, Proceedings of the National Academy of Sciences.

[17]  B. Liu,et al.  Abnormality of CD4+CD25+ regulatory T cells in idiopathic thrombocytopenic purpura , 2006, European journal of haematology.

[18]  H. Nagai,et al.  Src homology 2 domain‐containing protein tyrosine phosphatase substrate 1 regulates the induction of Langerhans cell maturation , 2006, European journal of immunology.

[19]  M. Baccarani,et al.  Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes. , 2006, Experimental hematology.

[20]  T. K. van den Berg,et al.  Signal Regulatory Protein α Ligation Induces Macrophage Nitric Oxide Production through JAK/STAT- and Phosphatidylinositol 3-Kinase/Rac1/NAPDH Oxidase/H2O2-Dependent Pathways , 2005, Molecular and Cellular Biology.

[21]  Shimon Sakaguchi,et al.  Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization , 2005, The Journal of experimental medicine.

[22]  Yuka Kanno,et al.  Signaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4 , 2004, Immunological reviews.

[23]  N. Xing,et al.  Effects of B7-blocking agent and/or CsA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura. , 2003, Blood.

[24]  Eric J. Brown,et al.  Bidirectional Negative Regulation of Human T and Dendritic Cells by CD47 and Its Cognate Receptor Signal-Regulator Protein-α: Down-Regulation of IL-12 Responsiveness and Inhibition of Dendritic Cell Activation1 , 2001, The Journal of Immunology.

[25]  H. Gresham,et al.  Cd47-Signal Regulatory Protein α (Sirpα) Regulates Fcγ and Complement Receptor–Mediated Phagocytosis , 2001, The Journal of experimental medicine.

[26]  J. O’Shea,et al.  Inducible Expression of Stat4 in Dendritic Cells and Macrophages and Its Critical Role in Innate and Adaptive Immune Responses1 , 2001, The Journal of Immunology.

[27]  E. Brown,et al.  Integrin-associated protein (CD47) and its ligands. , 2001, Trends in cell biology.

[28]  O. Majdic,et al.  Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. , 2000, Blood.

[29]  Kenneth M. Murphy,et al.  Dendritic cell regulation of TH1-TH2 development , 2000, Nature Immunology.

[30]  P. Sansoni,et al.  Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients. , 2000, Experimental hematology.

[31]  B. Ludviksson,et al.  The effect of TGF‐β1 on immune responses of naïve versus memory CD4+ Th1/Th2 T cells , 2000, European journal of immunology.

[32]  C. Lagenaur,et al.  Role of CD47 as a marker of self on red blood cells. , 2000, Science.

[33]  C. Lagenaur,et al.  Negative Regulation of Phagocytosis in Murine Macrophages by the Src Kinase Family Member, Fgr , 2000, The Journal of experimental medicine.

[34]  V. Kuchroo,et al.  Studies in B7-Deficient Mice Reveal a Critical Role for B7 Costimulation in Both Induction and Effector Phases of Experimental Autoimmune Encephalomyelitis , 1999, The Journal of experimental medicine.

[35]  B. Neel,et al.  SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages , 1999, Current Biology.

[36]  Sheila M. Thomas,et al.  Regulation of Early Events in Integrin Signaling by Protein Tyrosine Phosphatase SHP-2 , 1999, Molecular and Cellular Biology.

[37]  C. Lagenaur,et al.  Integrin-associated Protein Is a Ligand for the P84 Neural Adhesion Molecule* , 1999, The Journal of Biological Chemistry.

[38]  M. Toda,et al.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. , 1998, International immunology.

[39]  J. Wahlström,et al.  Role of the T cell receptor in idiopathic thrombocytopenic purpura (ITP) , 1998, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[40]  Y. Ikeda,et al.  Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. , 1998, The Journal of clinical investigation.

[41]  A. Sharpe,et al.  Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. , 1998, Journal of immunology.

[42]  T. K. van den Berg,et al.  Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. , 1998, Journal of immunology.

[43]  B. Neel,et al.  Identification of Major Binding Proteins and Substrates for the SH2-Containing Protein Tyrosine Phosphatase SHP-1 in Macrophages , 1998, Molecular and Cellular Biology.

[44]  T. Kühne,et al.  Immune Thrombocytopenic Purpura ITP , 1998, Vox sanguinis.

[45]  M. Gadina,et al.  Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role. , 1998, Journal of immunology.

[46]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[47]  C. Lagenaur,et al.  The Murine P84 Neural Adhesion Molecule Is SHPS-1, a Member of the Phosphatase-Binding Protein Family , 1997, The Journal of Neuroscience.

[48]  M. Kasuga,et al.  Epidermal growth factor stimulates the tyrosine phosphorylation of SHPS-1 and association of SHPS-1 with SHP-2, a SH2 domain-containing protein tyrosine phosphatase. , 1997, Biochemical and biophysical research communications.

[49]  A. Omori,et al.  BIT, an immune antigen receptor‐like molecule in the brain 1 , 1997, FEBS letters.

[50]  A. Ullrich,et al.  A family of proteins that inhibit signalling through tyrosine kinase receptors , 1997, Nature.

[51]  Kazuki Sato,et al.  Activation of Protein-tyrosine Phosphatase SH-PTP2 by a Tyrosine-based Activation Motif of a Novel Brain Molecule* , 1996, The Journal of Biological Chemistry.

[52]  J. Freedman,et al.  Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. , 1996, Blood.

[53]  G. Tosato,et al.  IL-10 inhibits human T cell proliferation and IL-2 production. , 1992, Journal of immunology.

[54]  J. Gribben,et al.  B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Flavell,et al.  T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I–E , 1989, Nature.

[56]  G. Morahan,et al.  Tolerance of class I histocompatibility antigens expressed extrathymically , 1989, Nature.

[57]  Kailin Xu,et al.  Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia , 2011, International journal of hematology.

[58]  H. Shiku,et al.  Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura. , 2007, Thrombosis research.

[59]  Eman Monir,et al.  Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura. , 2006, The Egyptian journal of immunology.

[60]  T. Matozaki,et al.  SHPS-1 promotes the survival of circulating erythrocytes through inhibition of phagocytosis by splenic macrophages. , 2006, Blood.

[61]  A. Freitas,et al.  IPEX and FOXP3: clinical and research perspectives. , 2005, Journal of autoimmunity.

[62]  Nobuo Yamada,et al.  Generation of mature dendritic cells from a CD14+ cell line (XS52) by IL-4, TNF-alpha, IL-1 beta, and agonistic anti-CD40 monoclonal antibody. , 1999, Journal of immunology.